EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study

Brenda Laky, Daniel Huemer, Martin Eigenschink, Benedikt Sagl iD, Rainer Thell, Karl-Heinz Wagner iD, Werner Anderl, Philipp R Heuberer

Nutrients · 2024

DOI: 10.3390/nu16162695 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Brenda Laky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), 1050 Vienna, Austria. Hauptthemen laut MEDLINE: Dietary Supplements, Lumbar Vertebrae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Products & Drugs GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various nutritional supplements are available over the counter, yet few have been investigated in randomized controlled trials. The rationale for using the specific mix of nutritional substances including collagen type II, hyaluronic acid, n-acetyl-glucosamine, bamboo extract, L-lysine, and vitamin C is the assumption that combining naturally occurring ingredients of the intervertebral disc would maintain spine function. This double-blinded, placebo-controlled randomized trial aimed to evaluate the efficacy of a nutraceutical supplement mix in the management of lumbar osteochondrosis. Fifty patients were randomly assigned to either the supplement or placebo group in a 1:1 ratio. Patient-Reported Outcome Measures (PROMs) included the Oswestry Disability Index (ODI), the visual analogue scale for pain (pVAS), short form-12 (SF-12) physical and mental component summary subscale scores (PCS and MCS, respectively), and global physical activity questionnaire (GPAQ). Magnetic resonance imaging (MRI) was used to evaluate degenerative changes of intervertebral discs (IVD) including Pfirrmann grades as well as three-dimensional (3D) volume measurements. Data were collected at baseline and after the 3-month intervention. None of the PROMs were significantly different between the supplement and placebo groups. Disc degeneration according to Pfirrmann classifications remained stable during the 3-month intervention in both groups. Despite no significance regarding the distribution of Pfirrmann grade changes (improvement, no change, worsening; p = 0.259), in the supplement group, one patient achieved a three-grade improvement, and worsening of Pfirrmann grades were only detected in the placebo group (9.1%). Furthermore, in-depth evaluations of MRIs showed significantly higher 3D-measured volume changes (increase) in the supplement (+740.3 ± 796.1 mm3) compared to lower 3D-measured volume changes (decrease) in the placebo group (−417.2 ± 875.0 mm3; p < 0.001). In conclusion, this multi-nutrient supplement might not only stabilize the progression of lumbar osteochondrosis, but it might also potentially even increase IVD volumes as detected on MRIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsLumbar VertebraeHumansDouble-Blind MethodMaleFemaleMiddle AgedAdultIntervertebral Disc DegenerationTreatment OutcomeMagnetic Resonance ImagingPatient Reported Outcome MeasuresOsteochondrosisSpinal OsteochondrosisPain Measurement

Stichwörter der Autor:innen

L-lysinebamboo extractcollagen type IIhyaluronic acidlower back painmagnetic resonance images (MRI)n-acetyl-glucosamine

Autor:innen und Institutionen

  • Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), 1050 Vienna, Austria.
  • Austrian Society of Regenerative Medicine (RegMed), 1010 Vienna, Austria.
  • Faculty of Medicine, Sigmund Freud Private University Medicine, 1020 Vienna, Austria.
  • Center for Clinical Research, University Clinic of Dentistry, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.
  • Medical University of Vienna, 1090 Vienna, Austria.

ORCID-Profile: Benedikt Sagl, Karl-Heinz Wagner

Förderung

  • Natural Products &amp; Drugs GmbH

Zitieren

APA

Laky, B., Huemer, D., Eigenschink, M., Sagl, B., Thell, R., Wagner, K. H., Anderl, W., & Heuberer, P. R. (2024). A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study. Nutrients. https://doi.org/10.3390/nu16162695

Vancouver

Laky B, Huemer D, Eigenschink M, Sagl B, Thell R, Wagner KH, et al. A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study. Nutrients. 2024. doi:10.3390/nu16162695

BibTeX
@article{Laky2024,
  author = {Laky, Brenda and Huemer, Daniel and Eigenschink, Martin and Sagl, Benedikt and Thell, Rainer and Wagner, Karl-Heinz and Anderl, Werner and Heuberer, Philipp R},
  title = {A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162695}
}
Kostenlos starten →